Market Cap 23.38B
Revenue (ttm) 2.98B
Net Income (ttm) -719.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.18%
Debt to Equity Ratio 0.01
Volume 778,400
Avg Vol 1,180,918
Day's Range N/A - N/A
Shares Out 240.39M
Stochastic %K 3%
Beta 1.35
Analysts Strong Sell
Price Target $136.80

Latest News on BNTX

New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 6 days ago

New vaccine chief rocks pharmaceutical stocks

MRNA NVAX PFE GSK IBB SRPT XBI


BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 11:39 AM EDT - 8 days ago

BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript


Vaccine stocks fall following FDA resignation

Mar 31, 2025, 6:21 PM EDT - 6 weeks ago

Vaccine stocks fall following FDA resignation

MRNA NVAX PFE PCVX PTCT XBI


BioNTech SE (BNTX) Q4 2024 Earnings Call Transcript

Mar 10, 2025, 12:14 PM EDT - 2 months ago

BioNTech SE (BNTX) Q4 2024 Earnings Call Transcript


BioNTech Stock Drops as Sales Outlook Disappoints

Mar 10, 2025, 11:50 AM EDT - 2 months ago

BioNTech Stock Drops as Sales Outlook Disappoints


BioNTech guides for worse-than-expected 2025 revenue decline

Mar 10, 2025, 7:35 AM EDT - 2 months ago

BioNTech guides for worse-than-expected 2025 revenue decline


BioNTech Completes Acquisition of Biotheus

Feb 3, 2025, 6:45 AM EST - 3 months ago

BioNTech Completes Acquisition of Biotheus


US FDA lifts partial clinical hold on BioNTech cancer drug study

Dec 13, 2024, 4:12 PM EST - 5 months ago

US FDA lifts partial clinical hold on BioNTech cancer drug study


Why Is BioNTech Stock Trading Higher On Friday?

Dec 6, 2024, 1:14 PM EST - 5 months ago

Why Is BioNTech Stock Trading Higher On Friday?


BioNTech buys China's Biotheus to support oncology strategy

Nov 13, 2024, 6:52 AM EST - 6 months ago

BioNTech buys China's Biotheus to support oncology strategy


BioNTech to Acquire Biotheus to Boost Oncology Strategy

Nov 13, 2024, 6:45 AM EST - 6 months ago

BioNTech to Acquire Biotheus to Boost Oncology Strategy


BioNTech SE (BNTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 1:05 PM EST - 6 months ago

BioNTech SE (BNTX) Q3 2024 Earnings Call Transcript


BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3

Nov 4, 2024, 9:41 AM EST - 6 months ago

BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3